Global Medical Discovery chooses our AntiCancer paper
Global Medical Discovery has identified your recent peer-reviewed publication: Oleic Acid, Deglycosylated Vitamin D-Binding Protein, Nitric Oxide: A Molecular Triad Made Lethal to Cancer as a Key Scientific Article contributing to excellence in biomedical research. We would therefore like to feature it in our next edition of Global Medical Discovery Series.
Global Medical Discovery features papers of exceptional scientific importance and intelligible to a broad scientific audience (for this week edition, https://globalmedicaldiscovery.com ). GMD is viewed almost 845,000 times each month by our audience of academic, clinical and industrial R&D Scientists and it is linked to the top 50 Biotechnology and Pharmaceutical companies as well as hundreds of world’s leading universities and research organizations.
Global Medical Discovery (GMD) [ISSN 1929-8536] is a Canadian based company established in 2002.
The senior management team has over 100 years of combined experience in top academic institutions and pharmaceutical industry.
GMD recognizes the contributions of scientists, and clinicians who have made major advances in the understanding, diagnosis, treatment, cure or prevention of human disease.
The readership of GMD includes pharmaceutical and related industries, universities, colleges, research institutions, and libraries.
The readership of GMD includes pharmaceutical and related industries, universities, colleges, research institutions, and libraries.
GMDis viewed almost 845,000 times each month by our audience of academic, clinical and industrial R&D Scientists and it is linked to the top 50 Biotechnology and Pharmaceutical companies as well as hundreds of world’s leading universities and research organizations.
Target Selection Team at GMD has identified our recent peer-reviewed publication: “Oleic Acid, Deglycosylated Vitamin D-Binding Protein, Nitric Oxide: A Molecular Triad Made Lethal to Cancer” as a Key Scientific Article contributing to excellence in biomedical research.
This article has been published in the January issue of GMD and it reports the novel results describing the successful treatment of a supposedly incurable cancers with The Swiss Protocol.
It also reports for the first time the successful transplantation of the third brain that made it possible to successfully remove a supposedly incurable cancer that occupied a great part of the brain without any neurological impairment.
A quote from the article in GMD reads:
“Here we present the case of a 73-year old man with a very large stage IV glioblastoma multiforme in his right hemisphere (Figure 1, left panel). The patient had been labeled incurable/inoperable and had been given a prognosis of a few weeks in June 2014. After the implementation of The Swiss Protocol®, the growth of the tumor was arrested and the patient could be operated in December 2014 with surgical eradication of the tumor (Figure 1, right panel). Interestingly, thanks to the successful reconstitution of the microbiome, often defined also as “the third brain”, the patient did not suffer any neurologic alteration and he is now recuperating all his functions despite the massive loss of cerebral tissue. This case, together with other successful results obtained in breast and pancreatic cancer patients, was presented, after peer-review, at the 9th International Conference of Anticancer Research, held in Ocotber 2014 in Greece. Overall, these results indicate that this novel integrated protocol has the potential to open a new perspective in cancer treatment.”
The article can be downloaded at:
https://globalmedicaldiscovery.com/key-clinical-research-articles/oleic-acid-deglycosylated-vitamin-d-binding-protein-nitric-oxide-molecular-triad-made-lethal-cancer/
